Myomancy ADHD, Dyslexia and Autism

May 2008

FDA Approvals: Amitiza, Strattera, NovoSeven RT - Medscape (subscription)

Strattera Approved for ADHD Maintenance Treatment - FDA news (subscription)

Atomoxetine approved by FDA for maintenance ADHD - Drug Topics Magazine

Eli Lilly gets FDA approval for ADHD drug Strattera - Hemscott

Eli Lilly (LLY) Receives FDA Approval of Strattera for Treatment … - StreetInsider.com (subscription)

FDA approves Strattera for ADHD maintenance - Prescribing Reference

Eli Lilly's Strattera wins FDA approval for maintenance of ADHD - Trading Markets (press release)

ALSO NOTED: Botox slowdown doesn't dampen Allergan's Q1; Shandong … - FiercePharma

Abbott: ABT-089 data for adult ADHD look promising - Pharmaceutical Business Review

FDA approves Eli Lilly’s Strattera for Maintenance Treatment for … - RTT News

FDA Approves Strattera(R) for Maintenance of ADHD in Children and … - FOXBusiness

Market Report — In Play (LLY) - MSN Money

FDA OKs Eli Lilly’s Strattera for maintenance of ADHD in children … - RTT News

FDA Approves Strattera(R) for Maintenance of ADHD in Children and … - Earthtimes (press release)

Eli Lilly gets FDA approval for ADHD drug Strattera - Forbes

April 2008

The ADHD drug Strattera: Lilly to issue warnings - TransWorldNews (press release)

The ADHD drug Strattera: Lilly to issue warnings - TransWorldNews (press release)

Treating ADHD Without Stimulants - U.S. News & World Report

Lilly Reports Solid First-Quarter Results - Earthtimes

Children Diagnosed with ADHD Should Get a Heart Checkup - Enews 2.0

Women with ADHD more impaired than men - China Post

The ADHD drug Strattera – 55 young persons have died - TransWorldNews (press release)

Commercial and Pipeline Insight: ADHD - Immature adult market … - Pharmaceutical Business Review

ADHD from a teen's point of view - Ventura County Star

Parents just wanted to say thanks for caring after son's death - Boston Globe

March 2008

Psychiatrists back sponsorship deals - The Australian

Why Drug Lawsuits are Necessary: FDA “isn’t capable of policing … - Tort Deform

Women with ADHD more impaired than men - China Daily

FDA: Cymbalta's Label, Packaging Changed To Cut Errors - CNNMoney.com

Lilly denies NY Times Zyprexa report - Medical Marketing and Media

UPDATE: FDA:Cymbalta's Label, Packaging Changed To Cut Errors - CNNMoney.com

Women with ADHD more troubled than men - TVNZ

FDA: Cymbalta's label, packaging changed to cut errors - MarketWatch

US: Eli Lilly E-Mail Discussed Unapproved Use of Drug - CorpWatch.org

ADHD from a teen's viewpoint - Santa Rosa Press Democrat

Did Lilly chief support off-label promos? - FiercePharma

Eli Lilly E-Mail Discussed Unapproved Use of Drug - New York Times

In e-mail, Zyprexa touted for youths - Indianapolis Star

ADHD memoir from a teenager's point of view - Monterey County Herald

Driven to distraction - Buffalo News

The trials of hyperactivity - Gainesville Sun

February 2008

ADHD from a teen's point of view - Kansas City Star

Teen gives insight into ADHD - San Jose Mercury News

Teen gives insight into ADHD - San Jose Mercury News

Teen addresses hyperactivity in own terms - San Francisco Chronicle

Manhattan Research Ranks the Top Pharmaceutical Branded Websites … - PharmaLive.com (press release)

Eli Lilly Q4 Profit Surges On Lower Charges, Higher Sales, Volume … - RTT News

ELI LILLY AND CO - Lifescience-online

January 2008

Lilly Caps Successful Year with Strong Fourth-Quarter Results - CNNMoney.com

Double Trouble at School: Stuttering and ADHD - Stuttering Foundation of America